| I N TR ODU C TI ON
Extensive neuroinflammation in Alzheimer's disease (AD) causes neuronal and synaptic loss, resulting in cognitive impairments. The molecular mechanisms underlying amyloid-induced synaptic dysfunction remain an area of interest. Silent glutamatergic synapses, which exhibit N-methyl-Daspartate (NMDA) receptor-mediated, but not AMPA (a-amino-3-hydroxy-5-methyl-4-isoxazoleproprionate) receptor-mediated, synaptic currents exist in several brain regions including the hippocampus (Liao, Hessler, & Malinow, 1995; Nusser et al., 1998; Petralia et al., 1999) . Neuronal activity recruits AMPA receptors to the postsynaptic site to activate silent synapses and increase the strength of synaptic transmission. (Isaac, Nicoll, & Malenka, 1995; Li, & Sheng, 2003) . Incorporation of inwardly rectifying and calcium-permeable GluR1-containing AMPA receptors at silent synapses serves as a critical step in the early phases of electrical stimuli-induced long-term potentiation (LTP) in the hippocampal CA1 pyramidal neurons (Morita, Rah, & Isaac, 2014) . Induction of silent synapses by sustained inactivation of neural circuits enhanced the LTP magnitude at Schaffer collateral CA1 synapses (Arendt, Sarti, & Chen, 2013) .
Synaptic dysfunction in AD is characterized by inhibition of LTP, facilitation of long-term depression, and loss of synaptic AMPA and/or NMDA receptors (Hsieh et al., 2006; Ting et al., 2007) . At present, the adaptation of hippocampal silent synapses and the underlying mechanisms remain elusive in the setting of AD.
Distribution and immobilization of AMPA receptors in the postsynaptic membrane depends on several intracellular processes including receptor biosynthesis, intracellular sorting process, actin cytoskeletonmediated membrane trafficking, and scaffold protein-mediated anchoring, clustering process, and synaptic activity (Isaac et al., 1995; Kerr, & Blanpied, 2012; Li et al., 2003) . The actin cytoskeleton system at the synapses plays a pivotal role in regulating the spine morphology, in anchoring/trafficking, and in dynamic localization of AMPAR subunits (Anggono, & Huganir, 2012; Kerr et al., 2012) , thus contributing to the induction and maintenance of synaptic plasticity in central neurons (Cingolani, & Goda, 2008; Yuen et al., 2010) . Binding of dephosphorylated cofilin (the active form of cofilin) to filamentous actin (F-actin) results in actin severing and depolymerization, which negatively regulates the actin dynamics and synaptic plasticity (Cingolani et al., 2008;  Hippocampus. 2018;1-8.
wileyonlinelibrary.com/journal/hipo Yuen et al., 2010) . Scaffold proteins in postsynaptic density (PSD) control the trafficking, anchoring, and clustering of glutamate receptors and adhesion molecules (Iasevoli, Tomasetti, & de Bartolomeis, 2013 ).
PSD95 is a major core scaffolding protein that anchors the glutamate receptors in PSD of excitatory synapses, regulates numerous aspects of synapse dynamics including synapse maturation and synaptic plasticity in central neurons (Elias, & Nicoll, 2007; Kim, & Sheng, 2004; Xu, 2011) . Knockdown of PSD95 suppressed the activation of silent synapses and blocked the induction of LTP in developing superficial superior colliculus neurons (Zhao, Murata, & Constantine-Paton, 2013) . In this study, we were interested in the potential role that impairment of actin cytoskeleton and scaffold proteins plays in the dysfunction of hippocampal silent synapses in the rodent model of AD.
We used behavioral, electrophysiological, and molecular approaches to test the hypothesis that accumulation of amyloid species results in the impairment of cytoskeleton protein (e.g., cofilin) and PSD scaffolding protein (e.g., PSD95), which decreases the distribution of GluR1 anchoring at PSD and leads to the dysfunction of glutamatergic synapses in the hippocampal CA1 and impairment of synaptic plasticity and cognition.
| M A TE RI A L S A ND M E TH ODS

| Animals
The Animal Care and Use Committee of Cleveland Clinic approved all animal procedures which were performed in accordance with guidelines of the National Institutes of Health. Animals were housed the Institutional Biological Rodent Unit on a 14/10-h light/dark cycle with water and food pellets available ad libitum. Adult male Sprague-Dawley rats (weighing 200-250 g) were purchased from Charles River (Wilmington, MA), and all experiments were performed during the light cycle. Behavioral testing was performed on eighth day after the hippocampal microinjection. The samples for morphological and immunoblotting studies were collected immediately after the behavioral testing.
The tissues were sampled within a range of 400 mm around the injection site.
| Microinjection of amyloid fibrils into the hippocampal CA1 area
Rats were anesthetized with sodium pentobarbital (45 mg/kg i.p.) and restrained in a stereotaxic apparatus (Bie et al., 2014) . Ab 1-40 fibrils were formed as described previously (Chacon, Barria, Soto, & Inestrosa, 2004) . Ab 1-40 fibrils (10 lg/3ll), Ab 40-1 (10 lg/3ll) or 3ll of artificial cerebrospinal fluid were injected stereotaxically and bilaterally into each hippocampus (anteroposterior: 23.5 mm, mediolateral: 6 2.0 mm, dorsoventral: 23.0 mm) (Paxinos & Watson, 1998 ) using a 10 ll Hamilton syringe with a 27 G stainless-steel needle at a rate of 0.5 ll/min.
This experimental model has been used for studying AD (Ahmed, Enam, & Gilani, 2010; Bie et al., 2014; Chacon et al., 2004; Shin et al., 1997; Wu et al., 2013a Wu et al., , 2013b . The accuracy of microinjection site was histologically verified afterward (Bie et al., 2014; Wu et al., 2013a Wu et al., , 2013b 
| Morris water maze
The Morris water maze test was performed to investigate the memory function of rats (Bie et al., 2014; Wu et al., 2013a Wu et al., , 2013b . A total of 10 rats were randomly included in each group, with a breakdown of 5 rats per group for two separate rounds of testing. Testing was conducted in all groups at the same time of the day (9:00 AM to 12:00 noon). The experimental apparatus consisted of a circular pool (180 cm in diameter, 45 cm high). An invisible platform (15 cm in diameter, 35 cm high) was placed 1.5 cm below the surface of the water. The swimming path of the rat was recorded by a video camera and analyzed using EthoVision XT software (Noldus Information Technology).
Each rat underwent four trials per day for five consecutive days. During each trial (memory acquisition), the animals were placed into the maze consecutively from four random points of the pool and were allowed to search for the platform for 120 s. If the animal did not find the platform within 120 s, they were gently guided to it. Rats were allowed to remain on the platform for 20 s. The latency for each trial was recorded for analysis. On Day 6, all rats were subjected to a probe trial (memory retrieval) in which the platform was removed, and each animal had 60 s to search the pool for the platform. All behavioral testing was performed by the same investigator blinded to the different treatment groups.
| Hippocampal slice preparation and whole-cell recordings
For these studies, a different cohort of 24 rats was utilized (n 5 8 per group). These rats underwent behavioral testing, as described before, but behavioral data were not included in the analysis. The electrophysiological recording was performed within 24 h (0-1 day) after the conclusion of behavioral testing. Rat brain slices containing the hippocampal CA1 area were prepared, as previously described (Bie et al., 2009a (Bie et al., , 2009b (Bie et al., , 2010 EPSCs were filtered at 2 kHz, digitized at 10 kHz, and acquired and analyzed using Axograph X software. If synaptic transmission was stable (<15% change in EPSC amplitude over 15 min), LTP was induced by a single high-frequency electric stimuli train (100 Hz for 1 s) (Bie et al., 2014; Wu et al., 2013a Wu et al., , 2013b . All electrophysiological experiments were performed at room temperature (21 6 1 8C).
| Detection and activation of silent glutamatergic synapses
The minimal stimulation-based silent synapse recordings were performed on the hippocampal CA1 neurons (Liao et al., 1995 150 mV, as rationalized previously (Isaac et al., 1995; Liao et al., 1995) .
The percentage of silent synapses was compared between the groups.
The activation of silent synapses was induced by pairing lowfrequency electric stimuli (Liao et al., 1995) . For the electric stimuli paradigm, synaptic plasticity was elicited by depolarizing the neuron to 0 mV and pairing low-frequency presynaptic activity at 2 Hz for 120 pulses with constant stimulus intensity. This paradigm was widely applied to activate the silent synapses in hippocampal CA1 neurons (Liao et al., 1995) .
| Synaptosomal preparations and protein extraction
The protocol for preparing synaptosomes was based on previous reports (Bie et al., 2014; Wu, Bie, & Naguib, 2016) . Hippocampal CA1
tissues from rats injected with saline or Ab 1-40 and were gently homogenized in ice-cold 0.32 M sucrose buffer at pH 7.4, and then centrifuged for 10 min at 1,000 g (4 8C). The supernatant was collected and centrifuged for 20 min at 10,000g (4 8C). The synaptosomal pellet was then resuspended in the lysis buffer (0.1% Triton X-100, 150 mM NaCl, 25 mM KCl, 10 mM Tris-HCl, pH 7.4, with protease inhibitors) at 4 8C for 10 min. For total protein preparations (Bie et al., 2014) , the hippocampal CA1 tissues from the saline-and amyloid fibrils-treated rats were homogenized on ice for 10 min in the lysis buffer containing 50 mM Tris-Cl, 150 mM NaCl, 0.02 mM NaN 2 , 100 lg/mL phenylmethyl sulfonyl fluoride, 1 lg/mL aprotinin, and 1% Triton X-100. The lysates were centrifuged at 14,000 rpm for 10 min at 4 8C, and the supernatant was used for SDS-polyacrylamide gel electrophoresis.
Protein concentrations were determined by using the Bio-Rad (Hercules, CA) protein assay kit.
| Immunoblotting
The protein samples were subjected to 7.5% sodium dodecyl sulfate polyacrylamide gel electrophoresis followed by immunoblot analysis.
The blots were incubated overnight at 4 8C with a rabbit polyclonal 
| Compounds and data analysis
Ab peptide consisting of residues 1-40 of the human wild type sequence (Ab 1-40 ) and reverse sequence peptide, Ab 40-1 was purchased from Bachem (Torrance, CA). D-2-amino-5-phosphonopentanoate, 6-cyano-2,3-dihydroxy-7-nitroquinoxaline, bicuculline, and other chemicals were purchased from Sigma Aldrich (St Louis, MO) or Tocris (Ellisville, MO).
Normality was tested using the Shapiro-Wilk test. For electrophysiological and behavioral analysis, the data were compared with two-way ANOVA. The data from the histological study, western blot, and other studies were analyzed using Student's t-test, one-way ANOVA test. Post hoc analyses were performed using Student-Newman-Keuls test. All statistical analyses were performed with BMDP statistical software (Statistical Solutions, Saugus, MA). Data were expressed as means 6 SEM or asbox-and-whiskers plots, with 25th to 75th percentiles, bars represent maximal and minimal values. For all tests, a two-tailed p < .05 was considered statistically significant.
| RE S U L TS
| Amyloid impairs the unsilencing of glutamatergic silent hippocampal synapses
The accuracy of the microinjection was histologically verified by using
an India ink to demonstrate the preciseness of the injection site in the hippocampal CA1 area (Fig 1a) . In addition, we performed immunostaining to demonstrate the existence of Ab 1-40 in the rats injected with Ab 1-40 after the completion of behavioral testing.
Next, we determined the percentage of silent glutamatergic synapses in hippocampal CA1 neurons using minimal stimulation-based recordings of EPSCs at 270 mV and 150 mV respectively (Liao et al., 1995) . As shown in Figure 1c , the percentage of silent synapses in the hippocampal CA1 in rats injected with Ab 1-40 was lower than that in We next examined the expression of glutamate receptor subunit GluR1 in the synaptosomal preparation of the hippocampal CA1 in rats.
As shown in Figure 2 , reduction of the immunosignal of GluR1 was observed in the hippocampal synaptosome in rats injected with Ab 1-40 , which indicated a potential reduction of GluR1 anchoring at PSD and may account for the failed activation of silent synapses by pairing lowfrequency electric stimuli in the modeled rodents.
| Amyloid impaired cytoskeletal actin dynamics and postsynaptic scaffolding protein
Previous studies have established that phosphorylation of cofilin serves as an important factor that regulates the trafficking and synaptic transports of AMPA receptor subunits in central neurons (Bernstein, & Bamburg, 2010 ). We performed immunoblotting to detect the expression of total and phosphorylated cofilin in hippocampal CA1 in the rats injected with Ab 1-40 fibrils or saline. We found that microinjection of 
| Microinjection of amyloid fibrils induced hippocampal glutamatergic dysfunction and memory deficiency
Considering the potential role of activation of silent synapses in the maintenance of synaptic plasticity in central neurons (Choquet, & Triller, 2013) , we next evaluated the function of hippocampal glutamatergic synaptic plasticity and cognition in the rats injected with amyloid fibrils. Consistent with our previous reports (Bie et al., 2014; Wu et al., 2013a Wu et al., , 2013b , as shown in Figure 5a 
| D ISC USSION
Silent synapses lacking AMPA receptors exist in several brain regions including the hippocampus (Liao et al., 1995; Nusser et al., 1998; Petralia et al., 1999) , and altered function of silent synapses occurs in a number of physiological and pathological conditions, including addiction (Dong, & Nestler, 2014; Huang et al., 2009; Ma et al., 2014) , memory deficits (Geinisman, 2000) and several brain disorders (Hanse, Seth, & Riebe, 2013) . Previous studies demonstrated that artificial manipulation to correlate the pre-and postsynaptic activity, for example, pairing low-frequency electric stimuli (Ma et al., 2014) and classical conditioning (Keifer, & Houk, 2011) , may induce synaptic incorporation of the calcium-permeable AMPAR subunit GluR1 resulting in an activation of silent synapses and the enhanced synaptic plasticity (Hanse et al., 2013) . Activation of silent synapses lacking AMPA receptors appears to be one of the principal postsynaptic mechanisms underlying the induction and expression of LTP induced by pairing low-frequency electric stimuli in the hippocampal CA1 neurons (Choquet et al., 2013; Liao et al., 1995) .
Abnormally increased or decreased AMPA receptors in silent synapses may lead to faulty neural connectivity and immature spine morphology and may contribute to the pathogenesis of neurodevelopmental disorders, such as autism spectrum disorders and intellectual disability (Penzes et al., 2011) . It was reported that Ab promoted the removal of synaptic AMPA and NMDA receptors in the hippocampal neurons resulting in synaptic dysfunction (Hsieh et al., 2006; Ting et al., 2007) . Based on these previous findings, we also noted in this study a substantial reduction of the percentage of silent synapses in the hippocampal CA1 neurons in rats injected with Ab 1-40 species, and the failure to activate the hippocampal silent synapses by pairing of lowfrequency electric stimuli in the modeled rodents. We also observed a reduction of GluR1 in the hippocampal synaptosome, which may underlie the failed activation of silent synapses by pairing lowfrequency electric stimuli in the modeled rodents. These observations may explain, at least partially, the impairment of hippocampal glutamatergic synaptic plasticity noted in the rodent AD models.
The actin cytoskeleton plays a critical role in AMPA receptor membrane trafficking, thus modulating synaptic plasticity and memory in the physiological and pathological settings (Yao, Qi, & Chen, 2006) . The actin depolymerizing factor (ADF)/cofilin family of actin-associated proteins regulates the dynamics of the actin cytoskeleton through their filament-severing and monomer-binding activities (Bernstein et al., 2010) , possibly modulating the spine size and morphology (Hotulainen, & Hoogenraad, 2010) and membrane trafficking of AMPA receptor subunits (Gu et al., 2010) . ADF/cofilin is inactivated by phosphorylation of its serine-3 (Ser3) residue by LIM kinases and activated by dephosphorylation by specific phosphatases (Aizawa et al., 2001) . Ab oligomers appear to disturb the activity of p21-activated kinase-cofilin signaling, which contributes to the cognitive deficiency in AD (Zhao et al., 2006) . A recent study reported that the suppression of glutamate receptor surface expression and synaptic function in frontal cortical neurons was correlated with the reduction of phosphorylated cofilin in a mouse model of familial AD (Deng et al., 2016) , although others have noted an increased cofilin1 phosphorylation in the AD mouse (APP/ PS1) model (Barone, Mosser, & Fraering, 2014) . It was also reported that injection of a cofilin dephosphorylation inhibitory peptide to familial AD mouse models resulted in a partial rescue of the surface expression of glutamate receptor subunits and cognitive capacity (Deng et al., 2016) . Based on these previous studies, we found in this study a reduction of phosphorylated cofilin, which coincided with the reduced synaptosomal GluR1, and resulted in impairment of the glutamatergic synaptic plasticity and cognition in rats injected with amyloid fibrils.
The reduction of phosphorylated cofilin, considering its function to regulate actin cytoskeleton and synaptic plasticity, appears to contribute to the decreased expression of GluR1 in hippocampal synaptosome and dysfunction of silent synapses in the rodent of AD.
As eloquently stated by Choquet and Triller, "Central synapse is a multiscale dynamic organelle whose function is intimately linked to movement of its individual components in space and time" (Choquet et al., 2013) . PSD scaffold proteins (e.g., PSD95, Shank, GKAP, SAP70) regulate the trafficking, anchoring, and clustering of glutamate receptors and adhesion molecules, which is considered crucial in the For box-and-whiskers plots, the box extends from the 25th to 75th percentiles, a line within the box marks the median. Whiskers (error bars) above and below the box represent the minimum and maximum values [Color figure can be viewed at wileyonlinelibrary.com] modulation of synaptic plasticity and brain functions (Iasevoli et al., 2013) . For instance, PSD95 can be recruited by the trans-synaptic adhesive molecules and promote the membrane diffusible AMPA receptors trapped in the synaptic cleft (Choquet et al., 2013) and GluR1 subunit membrane trafficking in the central neurons (Swayze et al., 2004) . Knockdown of PSD95 decreased the postsynaptic AMPA and NMDA receptors and blocked the induction of LTP in central neurons (Zhao et al., 2013) . Treatment with low concentration of Ab induced early and transient (16-72 h) increase of synaptophysin and PSD95, followed by a decrease coincident with neuronal death (7d) in the organotypic hippocampal cultures (Merlo, Spampinato, Capani, & Sortino, 2016) . Reduced expression of PSD95 was reported in the brain of rodent model of AD (Savioz et al., 2014) . It was also reported that treatment with retinoid X receptor agonist bexarotene improved the remote memory stabilization in fear conditioning and olfactory crosshabituation, which was correlated with significant increases in the expression of PSD95 in 5XFAD mice (Mariani et al., 2017) . Based on these findings, we further identified that a reduction of synaptosomal PSD95 expression corresponded with the reduction of synaptic GluR1
and dysfunction of silent synapses in the hippocampal CA1 in rats injected with amyloid fibrils. Given the potential role of PSD95 in regulating AMPA receptor subunits trafficking and synaptic plasticity, the decreased expression of PSD95 may be implicated in the reduced expression of GluR1 in hippocampal synaptosome and dysfunction of silent synapses in the rodent AD model.
In conclusion, this study demonstrated a reduction of hippocampal silent synapses, which failed to be activated by pairing low-frequency stimuli in the rodent model of AD. These findings may, at least partially, result from the impairment of the actin cytoskeleton and PSD scaffold proteins in the central neurons.
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